Labcorp Holdings (LH) Liabilities from Discontinued Operations (2017 - 2022)
Labcorp Holdings' (LH) quarterly Liabilities from Discontinued Operations came in at $898.9 million in Q4 2022, up 990.9% quarter-over-quarter from $82.4 million in Q2 2018.
Powered by 
Analysis
Labcorp Holdings (LH) Liabilities from Discontinued Operations (2017 - 2022) Analysis & Trends
Labcorp Holdings has disclosed Liabilities from Discontinued Operations across 3 years of filings, most recently posting $898.9 million for Q4 2022.
- In Q4 2022, Liabilities from Discontinued Operations changed N/A year-over-year to $898.9 million; the TTM figure through Dec 2022 stood at $898.9 million (changed N/A YoY), while the FY2022 annual figure was $898.9 million, changed N/A from the prior year.
- Liabilities from Discontinued Operations came in at $898.9 million for Q4 2022 at Labcorp Holdings, up from $82.4 million in the prior quarter.
- In the past five years, Liabilities from Discontinued Operations ranged from a high of $898.9 million in Q4 2022 to a low of $82.4 million in Q2 2018.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Natera | 49.39 Bn | 48.29 Bn | 486.15 Mn |
| 2 | Quest Diagnostics | 27.49 Bn | 26.86 Bn | 1.03 Bn |
| 3 | Labcorp Holdings | 26.51 Bn | 26.37 Bn | 1.11 Bn |
| 4 | Guardant Health | 23.17 Bn | 22.12 Bn | 219.03 Mn |
| 5 | Tempus AI | 12.59 Bn | 11.77 Bn | 274.25 Mn |
| 6 | Caris Life Sciences | 8.01 Bn | 7.22 Bn | 182.38 Mn |
| 7 | Sotera Health | 5.53 Bn | 5.17 Bn | 177.96 Mn |
| 8 | BillionToOne | 4.80 Bn | 4.25 Bn | 77.11 Mn |
| 9 | Adaptive Biotechnologies | 4.40 Bn | 4.05 Bn | 51.39 Mn |
| 10 | iRhythm Holdings | 3.68 Bn | 3.08 Bn | 163.21 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2022 | 898.90 Mn |
| Jun 30, 2018 | 82.40 Mn |
| Dec 31, 2017 | 66.30 Mn |